OPRX Q2 2024 Earnings — OptimizeRx Corporation Revenue & Financial Results | Market Cap Arena

OPRXOptimizeRx Corporation

$128M

Q2 2024 Earnings

Healthcare Medical - Healthcare Information Services

Income Statement

Revenue

$19M+36.1% YoY

Gross Profit

$12M62.2% margin

Operating Income

-$4M-19.9% margin

Net Income

-$4M-21.3% margin

EPS (Diluted)

$-0.22

QoQ Revenue Growth

-4.5%

Cash Flow

Operating Cash Flow

$782,000

Free Cash Flow

$697,000

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$173M

Total Liabilities

$52M

Stockholders' Equity

$121M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$19M	$14M	+36.1%
Gross Profit	$12M	$8M	+49.6%
Operating Income	-$4M	-$5M	+22.7%
Net Income	-$4M	-$4M	+3.7%